Where can i buy aimovig?

Where can I buy Aimovig without a prescription?

Aimovig requires a prescription in every country where it is approved. No legitimate pharmacy sells it over the counter.

Where is Aimovig available for purchase?

It is stocked at most major retail pharmacies, specialty pharmacies, and hospital outpatient pharmacies once a prescription is presented. Online pharmacies that require an uploaded prescription can also dispense it.

How much does Aimovig cost without insurance?

List price for one 70 mg or 140 mg autoinjector is roughly $730–$750 in the United States. A 28-day supply therefore runs about $730–$1,500 depending on dose. Cash prices at independent pharmacies and online discount programs can be 10–30 % lower.

What discount programs or patient assistance options exist?

Amgen offers a copay card that can reduce out-of-pocket cost to as little as $5 per month for commercially insured patients. Uninsured or underinsured patients may qualify for the Amgen Safety Net Foundation program, which provides the drug at no cost. GoodRx and similar coupon sites list local cash prices that sometimes fall below $600 per dose.

When does the Aimovig patent expire?

The primary U.S. patent covering the erenumab molecule expires in 2032, with some formulation patents extending to 2035. Biosimilar entry before then is unlikely.

Who makes Aimovig?

Amgen manufactures the drug and markets it in the United States; Novartis holds ex-U.S. rights in many regions.

How does Aimovig compare with other CGRP monoclonal antibodies?

Aimovig (erenumab) was the first approved CGRP-receptor antibody. Ajovy (fremanezumab) and Emgality (galcanezumab) target the CGRP ligand itself. All three show similar monthly-migraine-day reductions in head-to-head analyses, but injection frequency and approved doses differ.

What side effects are patients asking about?

Constipation is the most frequently reported side effect. Injection-site reactions, muscle cramps, and rare hypersensitivity reactions also appear in post-marketing reports.

[1] https://www.drugpatentwatch.com/drug/aimovig
[2] https://www.amgen.com/products/aimovig